Minister of Health Dr. Ahmed Al-Awadhi has issued four key ministerial decisions establishing an integrated regulatory framework for imported medical products, human medicines, and cosmetic materials. The measures aim to align Kuwait’s health market with international best practices while enhancing safety, quality, and regulatory efficiency.

The first decision assigns exclusive authority to the Drug and Medical Products Registration and Control Administration to release and authorize the circulation of medical products. It also sets clear requirements for importing human, veterinary, plant, and herbal medicines, as well as health products, cosmetics, medical devices, and laboratory supplies, ensuring product safety from entry into the country to market distribution, reports Al-Rai daily.

The second decision mandates that all human medicines undergo a pre-registration process, allowing electronic verification of certificates to replace paper documentation. It introduces eight regulatory tracks for medicine registration, offering flexibility based on product type and evaluation requirements.

The third decision implements a comprehensive framework defining procedures and conditions for registering and evaluating human medicines. It sets clear timeframes for evaluation processes, improving transparency, predictability, and decision-making efficiency.

The fourth decision establishes regulations for registering cosmetic products for marketing, specifying regulatory requirements and setting the registration validity period at five years. It empowers authorities to suspend or cancel registrations in cases of proven violations by the product, manufacturer, or marketing company, reinforcing consumer protection.

Together, these measures aim to modernize Kuwait’s regulatory system, streamline processes for industry stakeholders, and enhance public confidence in the safety and quality of health and cosmetic products.